Octagon Capital Advisors »

Structure Therapeutics shares owned by Octagon Capital Advisors

Quarter-by-quarter ownership of Structure Therapeutics (GPCR) shares owned by Octagon Capital Advisors from 13F filings

Historical chart of Octagon Capital Advisors investment in Structure Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Structure Therapeutics held by Octagon Capital Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Structure Therapeutics by Octagon Capital Advisors

Quarter filed Position value Share count Share price at filing
2024-09-30 $53M 1.2M 43.89
2024-06-30 $45M 1.1M 39.27
2024-03-31 $22M 507k 42.86
2023-12-31 $17M 414k 40.76
2023-06-30 $3.1M 75k 41.57
2023-03-31 $2.2M 94k 23.79

More positions owned by Octagon Capital Advisors

Apellis Pharmaceuticals (APLS)
Verona Pharma Sponsored Ads (VRNA)
Structure Therapeutics Sponsored Ads (GPCR)
Insmed Com Par $.01 Call Option (INSM)
Dianthus Therapeutics (DNTH)
Arrivent Biopharma (AVBP)
Centessa Pharmaceuticals Sponsored Ads (CNTA)
Nuvation Bio Com Cl A (NUVB)
Corbus Pharmaceuticals Hldgs Com New (CRBP)
Ocular Therapeutix (OCUL)
Miragen Therapeutics (VRDN)
Perspective Therapeutics Com New (CATX)
Mind Medicine Mindmed Com New (MNMD)
Cogent Biosciences (COGT)
Bridgebio Pharma (BBIO)

View all positions for Octagon Capital Advisors

Top funds holding Structure Therapeutics

Capital Research Global Investors
Henderson Group
Driehaus Capital Management
Federated Investors
BVF
T. Rowe Price Associates
RA Capital Management
Citadel Advisors
Logos Global Management
Capital Research and Management Company - Division 3
Point72 Asset Management
Octagon Capital Advisors
Vestal Point Capital
Rock Springs Capital Management
Deep Track Capital

View all funds holding Structure Therapeutics